IL6 and metabolic disease: Despite the lack of association with metabolic syndrome as a whole, IL-6 shows a stronger relationship with specific components of the syndrome, such as dyslipidemia and insulin resistance, which may point to its more targeted impact on the pathophysiology of metabolic disorders in middle-aged women (Table 3).